| PERIOD ENDING | 24-Sep-09 | 25-Jun-09 | 26-Mar-09 | 25-Dec-08 | | Total Revenue | 126,812 | 127,478 | 113,789 | 177,755 | | Cost of Revenue | 102,938 | 107,020 | 100,578 | 153,209 | | | Gross Profit | 23,874 | 20,458 | 13,211 | 24,546 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 14,164 | 15,200 | 13,869 | 15,485 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 9,710 | 5,258 | (658) | 9,061 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (416) | (332) | (340) | (411) | | Earnings Before Interest And Taxes | 9,294 | 4,926 | (998) | 8,650 | | Interest Expense | 1,447 | 1,627 | 1,777 | 2,099 | | Income Before Tax | 7,847 | 3,299 | (2,775) | 6,551 | | Income Tax Expense | 3,081 | (652) | (286) | 712 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,766 | 3,951 | (2,489) | 5,839 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,766 | 3,951 | (2,489) | 5,839 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,766 | $3,951 | ($2,489) | $5,839 |
|
0.31% Nasdaq 0.00%
Income Statement
